author-photo

Veronique Cruciani

Bayer

6

Papers

72

Citations

Citation Trend

Filter By

Papers (6) Sort By

Journal Conference Others

Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapy.

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive Cancers.

2019 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (36)
Synergistic Effect of a HER2 Targeted Thorium-227 Conjugate in Combination with Olaparib in a BRCA2 Deficient Xenograft Model

2019 Pharmaceuticals
Show All
- Source
- Cite
- Save
Citations (11)
Targeted Alpha Therapy with anti-HER2 Thorium-227 Antibody-chelator Conjugates (HER2-TTCs) in Mouse Xenograft Models with Varying Levels of HER2 Expression and Resistance to Current State-of-the-art Therapies

2019 Journal of Medical Imaging and Radiation Sciences
Show All
- Source
- Cite
- Save
Citations (0)
Synergistic Effect of a Mesothelin Targeted Thorium-227 Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft Models

2019 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (25)
Synergistic Effect of a HER2 Targeted Thorium-227 Conjugate in Combination with olaparib in a BRCA2 Deficient Xenograft Model

2019 Journal of Medical Imaging and Radiation Sciences
Show All
- Source
- Cite
- Save
Citations (0)